SNMMI Launches Thyroid Cancer Registry Pilot
SNMMI has launched the pilot phase of the Thyroid Cancer Registry within its Radiopharmaceutical Therapy Registry platform to collect real-world data on radiopharmaceutical therapies, support research, and improve patient outcomes, with a full launch expected by the end of 2025.